Renaissance Technologies’s BioVie BIVI Stock Holding History

Renaissance Technologies’s Portfolio BIVI Stock Details BIVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$95.1K	Buy	67,918 +39,900	+142%	+$51.3K	﹤0.01%	3037
2025 Q4	$32.5K	Sell	28,018 -44,900	-62%	-$72.3K	﹤0.01%	3115
2025 Q3	$139K	Buy	+72,918	New	+$295K	﹤0.01%	3210
2024 Q2	–	Sell	-3,474	Closed	-$184K	–	3508
2024 Q1	$184K	Buy	+3,474	New	+$356K	﹤0.01%	3246
2023 Q1	–	Sell	-2,973	Closed	-$2.31M	–	3983
2022 Q4	$2.31M	Buy	2,973 +2,738	+1,165%	+$1.48M	﹤0.01%	1989
2022 Q3	$59K	Buy	235 +75	+47%	+$17.8K	﹤0.01%	3710
2022 Q2	$23K	Buy	+160	New	+$48K	﹤0.01%	4104
2021 Q4	–	Sell	-531	Closed	-$355K	–	3900
2021 Q3	$355K	Buy	531 +252	+90%	+$270K	﹤0.01%	3024
2021 Q2	$473K	Buy	+279	New	+$434K	﹤0.01%	2984

Other funds holding BIVI

Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return

PCM

Prelude Capital Management New York $1.31B AUM 62.01% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PTC

Philadelphia Trust Company Philadelphia, Pennsylvania $1.42B AUM 43.77% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Renaissance Technologies's BIVI Position: Q1 2026 in Review

Renaissance Technologies increased its BioVie (BIVI) stake by 142% in Q1 2026, buying an estimated $51.3K and bringing the position to 67,918 shares worth $95.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3037.

Renaissance Technologies first reported a position in BIVI in Q2 2021 and has held it in 9 quarters since. The position peaked at $2.31M in Q4 2022. 33 funds tracked by Wall St. Rank hold BIVI as of Q1 2026.

Renaissance Technologies held 67,918 shares of BioVie worth $95.1K as of Q1 2026.
Renaissance Technologies bought 39,900 BioVie shares in Q1 2026, an estimated $51.3K.
BioVie made up ﹤0.01% of Renaissance Technologies's portfolio in Q1 2026, its #3037 holding.
Renaissance Technologies first reported a position in BioVie in Q2 2021 and has held it in 9 quarters since.
Renaissance Technologies's BioVie position peaked at $2.31M in Q4 2022.
33 funds tracked by Wall St. Rank held BioVie as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.